Protara Therapeutics, Inc. - Common Stock (TARA)

50 filings reported holding TARA - Protara Therapeutics, Inc. - Common Stock as of Q2 2024.
Protara Therapeutics, Inc. - Common Stock (TARA) has 39 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC). These institutions hold a total of 10.4M shares of 38.5M outstanding shares and own 27.17% of the company stock.
Largest 10 shareholders include Opaleye Management Inc. (2.3M shares), RA CAPITAL MANAGEMENT, L.P. (1.9M shares), STEMPOINT CAPITAL LP (984K shares), Boxer Capital, LLC (812K shares), CITADEL ADVISORS LLC (665K shares), BAKER BROS. ADVISORS LP (537K shares), ARMISTICE CAPITAL, LLC (520K shares), Velan Capital Investment Management LP (480K shares), VANGUARD GROUP INC (428K shares), and CVI Holdings, LLC (303K shares).
This table shows the top 39 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.